Rheinmetall Secures €21 Million Order for 155mm Artillery Ammunition with Delivery Set for 2025

Rheinmetall Secures €21 Million Order for 155mm Artillery Ammunition with Delivery Set for 2025

(IN BRIEF) Rheinmetall has secured a €21 million contract to supply an international customer with 155mm M107 artillery ammunition, scheduled for delivery in the first half of 2025. The ammunition will be produced by Rheinmetall Expal Munitions in Spain. The M107 shell is widely used by NATO nations and compatible with a variety of 155mm weapon systems. Rheinmetall, a leading manufacturer of large-caliber ammunition, is increasing its production capacity and aims to produce up to 1.1 million 155mm artillery shells annually by 2027.

(PRESS RELEASE) DÜSSELDORF, 13-Jan-2024 — /EuropaWire/ — Rheinmetall has secured a significant contract to supply 155mm M107 artillery ammunition to an international customer, with an order valued at €21 million. The delivery of this substantial order is scheduled for the first half of 2025, following its booking in December 2024.

The ammunition will be produced by Rheinmetall Expal Munitions in Spain. The M107 shell, a long-standing staple of NATO forces, remains one of the most widely used artillery projectiles globally. It is compatible with a variety of 155mm weapon systems, making it a versatile choice for modern military operations.

As a leading manufacturer of large-caliber ammunition, Rheinmetall has been ramping up its production capabilities since 2022. By 2027, the company plans to reach an annual production capacity of up to 1.1 million 155mm artillery shells.

Rheinmetall’s extensive range of weapons and ammunition spans from medium-caliber rounds for infantry fighting vehicles and anti-aircraft guns to tank shells, aircraft armament, and high-energy laser applications.

Media Contact:

Oliver Hoffmann
Head of Press and Public Relations
Phone: +49 211 473-4748
Fax: +49 211 473-4157

SOURCE: Rheinmetall

MORE ON RHEINMETALL, ETC.:

Follow EuropaWire on Google News
EDITOR'S PICK:

Comments are closed.